Related Experiment Video
Updated: Aug 14, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Polycaprolactone-block-poly(ethylene oxide) micelles: a nanodelivery system for 17beta-estradiol
Patrick Lim Soo1, Jasmina Lovric, Patricia Davidson
1Department of Chemistry, McGill University, Montreal, Quebec H3A 2K6, Canada.
Molecular Pharmaceutics
|December 6, 2005
Summary
Researchers developed biocompatible polycaprolactone-block-poly(ethylene oxide) micelles for delivering 17beta-estradiol (E2). These micelles offer high loading efficiency and controlled release, retaining E2
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Existing hormone replacement therapies require improved delivery systems.
- There is a need for easily controllable and biocompatible drug delivery platforms.
- Steroids and other poorly water-soluble drugs often require advanced solubilizing agents.
Purpose of the Study:
- To develop and characterize biocompatible polycaprolactone-block-poly(ethylene oxide) (PCL-b-PEO) micelles for 17beta-estradiol (E2) delivery.
- To investigate the loading and release properties of E2 from these novel micelles.
- To confirm the retention of E2's biological activity after micelle formulation.
Main Methods:
- Synthesis and characterization of PCL-b-PEO micelles using transmission electron microscopy and dynamic light scattering.
- Determination of E2 loading efficiency and capacity via fluorescence spectroscopy.
- Analysis of E2 release kinetics under perfect sink conditions and assessment of diffusion coefficients.
- In vitro and in vivo studies to confirm biological activity.
Main Results:
- Spherical micelles (20-40 nm) were successfully prepared.
- High E2 loading efficiency (up to 96%) and capacity (up to 190% w/w) were achieved.
- E2 release exhibited a biphasic profile (initial burst, followed by sustained release up to 5 days) and was diffusion-controlled.
- Biological activity of E2 was preserved.
Conclusions:
- PCL-b-PEO micelles represent an efficient nanodelivery system for 17beta-estradiol.
- Drug loading and release kinetics can be modulated by altering micelle composition and initial drug concentration.
- This micelle carrier shows potential for delivering steroids and other hydrophobic drugs.
More Related Videos
10:53Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.